唾液电刺激治疗放疗诱导的口干症(LEONIDAS-2):一项多中心、随机、双盲、假对照3期试验
LEONIDAS-2多中心双盲随机假对照3期试验纳入86例放疗诱导口干症的头颈癌生存者,按1:1分配至活动性口内定制可摘电刺激装置或假装置使用12个月。意向性治疗分析显示主要结局(12个月时口干视觉模拟量表改善30%的患者比例)及所有次要临床或生活质量结局组间均无统计学差异;探索性分析显示EORTC QLQ-H&N35口干子量表评分随时间变化有利于活动干预组。
要点
- 主要结局12个月时口干视觉模拟量表改善30%的患者比例组间无统计学差异。
- 所有次要临床或生活质量结局组间均无统计学差异。
- 探索性分析显示EORTC QLQ-H&N35口干子量表评分随时间变化有利于活动干预组。
核心结论
- LEONIDAS-2未达到主要和次要结局。
研究设计与样本
- 多中心、双盲、随机、假对照临床试验,采用计算机生成的随机化列表按1:1分配参与者。
- 参与者被分配至活动性口内定制可摘电刺激装置或假装置,使用12个月。
- 按方案招募86名参与者。
- 主要结局为12个月时报告口干视觉模拟量表改善30%的患者比例。
- 通过经验证的测量(唾液测定法和视觉模拟量表)及生活质量问卷(EORTC QLQ-H&N35、OH-QoL16和SF-36)评估次要和探索性结局。
主要发现
- 意向性治疗分析显示主要结局组间无统计学证据表明差异。
- 意向性治疗分析显示任何次要临床或生活质量结局组间均无统计学证据表明差异。
- 探索性分析显示EORTC QLQ-H&N35口干子量表评分随时间变化组间有统计学显著差异,有利于活动干预组。
局限性
- LEONIDAS-2未达到主要和次要结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy-induced xerostomia significantly affects quality of life in head and neck cancer survivors. Neuro-electrostimulation of the salivary glands may safely increase natural salivation and reduce dry mouth symptoms. METHODS AND MATERIALS: This multicenter, double-masked, randomized, sham-controlled clinical trial assessed the long-term effects of a commercially available intraoral neuro-electrostimulating device in lessening xerostomia symptoms, increasing salivary flow, and improving quality of life in individuals with radiation therapy-induced xerostomia. Using a computer-generated randomization list, participants were assigned (1:1) to an active intraoral custom-made removable electrostimulating device or a sham device to be used for 12 months. The primary outcome was the proportion of patients reporting a 30% improvement on the xerostomia visual analog scale at 12 months. A number of secondary and exploratory outcomes were also assessed through validated measurements (sialometry and visual analog scale) and quality-of-life questionnaires (EORTC QLQ-H&N35, OH-QoL16, and SF-36). RESULTS: As per protocol, 86 participants were recruited. Intention-to-treat analyses showed no statistical evidence of a difference between the study groups with respect to the primary outcome or for any of the secondary clinical or quality-of-life outcomes. Exploratory analyses showed a statistically significant difference in the changes over time of the dry mouth subscale score of the EORTC QLQ-H&N35 in favor of the active intervention. CONCLUSIONS: LEONIDAS-2 did not meet the primary and secondary outcomes.
引用
- Mercadante V, Hamad AA, McCaul J, et al. Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2023. PMID: 36933846. doi:10.1016/j.ijrobp.2023.03.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。